海達股份(300320.SZ):擬以債轉股及現金方式向新加坡子公司增資並通過該子公司同步向羅馬尼亞孫公司增資
格隆匯5月8日丨海達股份(300320.SZ)公佈,爲促進羅馬尼亞海達的業務發展,並優化其資產負債結構,提升市場競爭力,增強盈利能力,結合公司戰略發展規劃,公司擬將其對新加坡海達的債權375萬美元轉作其對新加坡海達的增資款,新加坡海達將其對羅馬尼亞海達的債權305萬美元轉作對羅馬尼亞海達的增資款;同時,公司以其自有資金190萬美元向新加坡海達增資,並通過新加坡海達實現對羅馬尼亞海達190萬美元的增資,本次增資完成後,羅馬尼亞海達的註冊資本爲565萬美元,新加坡海達註冊資本爲565.75萬美元,仍持有羅馬尼亞海達100%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.